Medytox said Monday it will buy back 64,350 of its own shares on the open market to stabilize its share price and enhance shareholder value.
The buyback is valued at 5 billion won (approximately $3.23 million) and is scheduled to run from June 10 through Sept. 9.
jiyoon436@heraldcorp.com
